A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE2
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
STRIDE - STimulating Immune Response In aDvanced brEast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor
- Status
- TERMINATED
- Phase
- PHASE1
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Study of Unrelated Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE2